← Back to Search

Procedure

SURE vs. Standard Ureteroscopy for Kidney Stones

N/A
Waitlist Available
Research Sponsored by Calyxo, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Presence of renal stone(s)
Candidate for ureteroscopy with laser lithotripsy
Must not have
Bladder, ureteral or kidney abnormalities
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
No Placebo-Only Group

Summary

This trial is comparing a new method called the SURE procedure for removing kidney stones to the traditional basket method. It aims to see which method works better and has fewer side effects for patients who need kidney stone removal.

Who is the study for?
This trial is for individuals who need treatment for kidney stones and are candidates for a procedure called ureteroscopy with laser lithotripsy. Participants must be able to attend all follow-up procedures, understand the study, and have signed consent. It's not open to pregnant people, those with a BMI over 45, significant other health issues, or abnormalities in the bladder, ureter or kidneys.
What is being tested?
The study compares two methods of removing kidney stones: SURE (Steerable Ureteroscopic Renal Evacuation) versus standard basketing during ureteroscopy. The goal is to determine which method has better outcomes for patients.
What are the potential side effects?
Potential side effects may include discomfort or pain from the procedure, bleeding, infection risk due to stone removal process and possible damage to urinary tract structures during intervention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have kidney stones.
Select...
I am a candidate for a procedure to remove kidney stones using lasers.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have issues with my bladder, ureter, or kidneys.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
SFR

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Standard Ureteroscopy (Basketing)Active Control1 Intervention
Group II: SUREActive Control1 Intervention

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The SURE procedure and similar stone evacuation techniques, such as laser lithotripsy, work by breaking kidney stones into smaller fragments that can be more easily passed or extracted. Laser lithotripsy uses focused laser energy to fragment the stones, while the steerable ureteroscopic renal evacuation system allows for precise targeting and removal of these fragments. This approach minimizes tissue damage and enhances the efficiency of stone removal, which is important for patients to reduce complications and improve recovery outcomes.
Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?New concepts in shock wave lithotripsy.

Find a Location

Who is running the clinical trial?

Calyxo, Inc.Lead Sponsor
1 Previous Clinical Trials
40 Total Patients Enrolled
1 Trials studying Kidney Stones
40 Patients Enrolled for Kidney Stones

Media Library

Standard Ureteroscopy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT04519294 — N/A
Kidney Stones Research Study Groups: Standard Ureteroscopy (Basketing), SURE
Kidney Stones Clinical Trial 2023: Standard Ureteroscopy Highlights & Side Effects. Trial Name: NCT04519294 — N/A
Standard Ureteroscopy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04519294 — N/A
~14 spots leftby Apr 2025